RAM
CLDX icon

Readystate Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Readystate Asset Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-46,520
Closed -$1.2M – 407
2025
Q3 		$1.2M Sell
46,520
-288,480
-86% -$6.68M 0.05% 181
2025
Q2 		$6.82M Buy
+335,000
New +$6.52M 0.21% 91
2025
Q1 		– Sell
-142,038
Closed -$3.59M – 625
2024
Q4 		$3.59M Sell
142,038
-37,480
-21% -$1.02M 0.11% 185
2024
Q3 		$6.1M Buy
+179,518
New +$6.84M 0.11% 275
2024
Q2 		– Sell
-49,457
Closed -$2.08M – 768
2024
Q1 		$2.08M Buy
+49,457
New +$2.03M 0.03% 551

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return